Lilly sees new 'urban' connection to HQ as recruiting tool

Eli Lilly's ($LLY) new CityWay buildings will connect the drugmaker's HQ to Indianapolis' downtown, creating a "new urban neighborhood" it hopes will help it recruit top young researchers. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.